Following up on its February 27 statement opposing the U.S. Drug Enforcement Administration’s proposed permanent changes to the e-prescribing of controlled medications, the American Telemedicine Association and its ATA Action sent its final comments this week…
Continue Reading
Sandy Still, Pharm.D., Director of Clinical Strategy at BluesightDrug diversion is an increasingly serious issue that tends to be substantially underestimated. In every instance, a potential threat to patient safety is present. This includes…
Continue Reading
There are so many challenges that we are currently facing in the world of healthcare, that possibly adding another one is overwhelming to think about. AI automation is still so new that it’s hard…
Continue Reading
Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…
